Payne Capital Management LLC purchased a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 12,775 shares of the company’s stock, valued at approximately $1,642,000. Merck KGaA makes up approximately 0.4% of Payne Capital Management LLC’s investment portfolio, making the stock its 16th largest position.
A number of other institutional investors also recently added to or reduced their stakes in the business. Frazier Financial Advisors LLC acquired a new position in Merck KGaA during the 2nd quarter worth approximately $25,000. Rakuten Securities Inc. acquired a new stake in shares of Merck KGaA in the 2nd quarter valued at approximately $27,000. Delos Wealth Advisors LLC acquired a new stake in shares of Merck KGaA in the 2nd quarter valued at approximately $33,000. Solstein Capital LLC purchased a new stake in shares of Merck KGaA in the second quarter valued at approximately $33,000. Finally, Burk Holdings LLC acquired a new position in Merck KGaA during the second quarter worth $39,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Trading Up 0.4%
OTCMKTS:MKGAF opened at $164.58 on Thursday. Merck KGaA has a 1 year low of $116.68 and a 1 year high of $175.56. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The stock has a fifty day moving average price of $163.19 and a two-hundred day moving average price of $148.83. The stock has a market capitalization of $21.27 billion, a price-to-earnings ratio of 25.13 and a beta of 0.96.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
